Takara Bio Stock

Takara Bio Current Assets

Delisted·Jun 12, 2026

The Current Assets of Takara Bio (4974.T) as of Aug 13, 2026 is 57.68 B JPY. In the previous year, Current Assets was 62.76 B JPY — a change of -8.09% (lower).

Current Assets

57.68 BJPY

YoY

-8.09%

Last updated:

Current Assets of Takara Bio is 2026 57.68 B JPY. Current Assets of Takara Bio was 2025 62.76 B JPY. It decreases by -8.09% lower compared to the previous year.
Access this data via the Eulerpool API

Takara Bio Stock analysis

What does Takara Bio do? Takara Bio Inc is a Japanese biotechnology company that has been active in the medical and life science industry since its founding in 1967. The company is a strong player in the field of molecular biology and operates in several countries such as the USA, Europe, and Asia. Takara Bio Inc was established as an independent company in 1999, focusing exclusively on the production of molecular biology products. The company offers a wide range of products in the fields of research and diagnostics, including enzymes, PCR kits, vectors and plasmids, antibodies, proteins, and cell culture products. Takara Bio Inc is organized into two divisions: Life Science Research and Diagnostics. The Life Science Research division provides products and solutions for research and development in areas such as molecular biology, neuroscience, proteomics, and genomics. The Diagnostics division offers products and solutions for clinical diagnostics and drug development. Takara Bio Inc also specializes in the automation of molecular biology procedures and offers automated systems that can perform processes such as nucleic acid extraction, PCR, and sequencing. The company is committed to sustainability and environmental protection, adhering to strict environmental and quality standards in its production processes and implementing waste reduction and efficient resource utilization programs. Overall, Takara Bio Inc is a leading company in the field of molecular biology, offering a wide range of products and solutions for research and diagnostics, and has become a key player in the life science industry through its global expansion and ability to provide custom solutions. Takara Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Takara Bio stock

Current Assets of Takara Bio is 57.68 B JPY in 2026.

Current Assets of Takara Bio changed from 62.76 B JPY to 57.68 B JPY, representing a -8.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Takara Bio since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Takara Bio historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Takara Bio

All Key Metrics — Takara Bio